What is Cancer?
Cancer is a type of genetic disease that is often caused by accumulated DNA mutation. It normally takes a few years and even a decade of time to develop a malignant tumor from DNA mutation.
A breakthrough in ctDNA technology
Currently, there is a growing trend in early cancer screening by DNA examination worldwide. With the advances in sequencing technology, scientists have stepped forwards and demonstrated that ctDNA technology is applicable in most cancer types at both early and advanced stages.
What is ctDNA? A non-invasive cancer biomarker
Circulating Tumor DNA (ctDNA) is fragmented DNA that originates from cancerous cells and tumors. As a tumor grows, cancerous cells release these small pieces of DNA into the bloodstream both actively and passively. Owing to its high specificity to tumor, ctDNA is regarded as an effective yet non-invasive cancer biomarker.
Cure for Cancer, Closer than You Think
ctDNA technology, as a non-invasive method for cancer screening, presents a low-risk yet effective assessment complementing traditional biopsies. We believe ctDNA technology could help monitor your health progressively and protect you from cancer.
Catch cancer way before normal body check-up
As we all know, PET-CT could detect the presence of tumor. Yet, ctDNA technology leaps forwards by detecting the earliest alternation of DNA sequences in cancerous cells. It allows us to take action before tumor development and increases the chance of survival.
ctDNA screening procedure
Advantages of MYGENIA® ctDNA - Early Cancer screening
MYGENIA® ctDNA - Early Cancer Screening
Circulating tumour DNA (ctDNA) Genetic Test
A single test estimating your risk of common cancers